16062-69-4

Basic information

• Product Name: 2-propyl-4H-3,1-benzoxazin-4-one
• Synonyms: 2-propyl-4H-3,1-benzoxazin-4-one
• CAS NO: 16062-69-4
• Molecular Formula: C₁₁H₁₁NO₂
• Molecular Weight: 189.21054
• Mol File: 16062-69-4.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-propyl-4H-3,1-benzoxazin-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2-propyl-4H-3,1-benzoxazin-4-one(16062-69-4)
• EPA Substance Registry System: 2-propyl-4H-3,1-benzoxazin-4-one(16062-69-4)

Safety Data

• Hazardous Substances Data: 16062-69-4(Hazardous Substances Data)

Upstream product

• 108-24-7 acetic anhydride 
• 6328-94-5 2-[(1-oxobutyl)amino]benzoic acid 
• 106-31-0 butanoic acid anhydride 
• 118-92-3 anthranilic acid 
• 201230-82-2 carbon monoxide 
• 615-36-1 2-bromoaniline 
• 615-43-0 2-iodophenylamine 

Downstream Products

• 30006-31-6 N-butyryl-anthranilic acid anilide 
• 84312-85-6 2-propyl-3-(p-tolyl)quinazolin-4(3H)-one 
• 84312-75-4 1-(2-Carboxyphenyl)-2-n-propyltetrazole 
• 77557-01-8 1-propyl-1,3-dihydro-2H-benzo[d]imidazol-2-one 
• 84312-84-5 2-(β-Ethylstyryl)-4(3H)-quinazolinone 
• 84312-77-6 N-(2-Hydrazinocarbonyl-phenyl)-2-[2-propyl-benzo[d][1,3]oxazin-(4Z)-ylidene]-butyramide 
• 1044749-85-0 2-propyl-3-(4-{[3-(1-pyrrolidinyl)propyl]oxy}phenyl)-4(3H)-quinazolinone 
• 1293410-47-5 3-([(E)-(4-phenoxyphenyl)methylidene]amino)-2-propylquinazolin-4(3H)-one 
• 1293410-48-6 3-(((E)-[4-(4-nitrophenoxy)phenyl]methylidene)amino)-2-propylquinazolin-4(3H)-one 
• 1293410-49-7 3-((E)-[4-(4-methylphenoxy)phenyl]methylidene)amino-2-propylquinazolin-4(3H)-one 
• 1293410-50-0 3-(((E)-[4-(4-chlorophenoxy)phenyl]methylidene)amino)-2-propylquinazolin-4(3H)-one 
• 1293410-51-1 3-(((E)-[4-(4-bromophenoxy)phenyl]methylidene)amino)-2-propylquinazolin-4(3H)-one 
• 1293410-52-2 3-(((E)-[4-(4-fluorophenoxy)phenyl]methylidene)amino)-2-propylquinazolin-4(3H)-one 
• 1293410-53-3 3-(((E)-[4-(4-chloro-3-methylphenoxy)phenyl]methylidene)amino)-2-propylquinazolin-4(3H)-one 

Relevant articles and documents

Recyclable palladium-catalyzed carbonylative annulation of 2-iodoanilines with acid anhydrides: A practical synthesis of 2-alkylbenzoxazinones

A highly efficient heterogeneous palladium-catalyzed carbonylative annulation of 2-iodoanilines and acid anhydrides has been developed. The reaction proceeds effectively in toluene using N,N-diisopropylethylamine (DiPEA) as the base at 100 °C under 2 bar of CO and provides a novel, general, and practical method for the assembly of a wide variety of 2-alkylbenzoxazinones with high functional group tolerance and good to excellent yields. This supported palladium complex can be readily separated from the product and recovered by a simple filtration of the reaction solution and reused up to seven times with almost consistent catalytic efficiency.

A general palladium-catalyzed carbonylative synthesis of 2-alkylbenzoxazinones from 2-bromoanilines and acid anhydrides

(C), its (O)K! An efficient palladium-catalyzed carbonylative synthesis of 2-alkylbenzoxazinones has been developed (see scheme). By starting from 2-bromoanilines and acid anhydrides, the corresponding products were isolated in good yields. Copyright

Design, synthesis and potential 6 Hz psychomotor seizure test activity of some novel 2-(substituted)-3-{[substituted]amino}quinazolin-4(3H)-one

Thirty new 2-(substituted)-3-{[substituted]amino}quinazolin-4(3H)-one were designed and synthesized keeping in view the structural requirement of pharmacophore and evaluated for anticonvulsant activity and neurotoxicity. The anticonvulsant activity of the titled compounds was assessed using the 6 Hz psychomotor seizure test. The most active compound of the series was 3-({(E)-[3-(4-chloro-3-methylphenoxy)phenyl]methylidene}amino) -2-phenylquinazolin-4(3H)-one PhQZ 7, which showed 100% protection (4/4, 0.5 h) and 75% protection (3/4, 0.25 h) at a dose of 100 mg/kg in mice. A computational study was carried out for calculation of pharmacophore pattern and prediction of pharmacokinetic properties. Titled compounds have also exhibited good binding properties with epilepsy molecular targets such as glutamate, GABA (A) delta and GABA (A) alpha-1 receptors, in Lamarckian genetic algorithm based flexible docking studies.